# Bristol-Myers Squibb Company (BMY) — Q2-2016 Earnings Results

**Report date:** 2016-07-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2016

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Down 2.37%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.69 | N/A | +2.68% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management highlighted the positive EPS surprise as a sign of operational efficiency. However, they did not provide specific revenue guidance.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite the lack of revenue guidance.

> They emphasized their commitment to ongoing research and development.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

Bristol Myers Squibb's earnings report showed a positive EPS surprise, indicating better-than-expected profitability. However, the stock fell by 2.37%, likely due to the absence of revenue figures and guidance, which left investors uncertain about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2016_